Surrozen, Inc./DE
Current role
SRZN
Wen-Chen Yeh, M.D., Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Wen-Chen Yeh, M.D., Ph.D.
Surrozen, Inc./DE reported in an 8-K filed July 19, 2023 that Wen-Chen Yeh, M.D., Ph.D. was appointed Scientific Advisory Board, effective July 31, 2023.
“On July 14, 2023, Surrozen, Inc. and Wen-Chen Yeh, M.D., Ph.D., our Chief Scientific Officer, agreed that in connection with our planned restructuring and reduction-in-force, Dr. Yeh will cease serving as our Chief Scientific Officer and join our Scientific Advisory Board effective as of July 31, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Surrozen, Inc./DE (SRZN)
SEC 8-K
Current2023-07-31–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Surrozen, Inc./DE
Other people whose current roles at this company are on record from its filings.
- Gad Soffer CEO
- Tim Kutzkey Chairman
- Andrew Maleki CFO
- Charles Williams COO
- Anna Berkenblit Board Member
- Christopher Y. Chai Board Member
- Craig Parker Board Member
- David J. Woodhouse Board Member
- Eric Bjerkholt Board Member
- Mace Rothenberg Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.